Physician profile
David Cresap
NPI 1457863334
$1,412.64
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $875 · 2023: $159 · 2024: $55.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $309.52 | 2021-2023 | |
| Abbott Laboratories | $172.90 | 2021-2024 | Freestyle Libre 3, Prodigy |
| Astrazeneca Pharmaceuticals LP | $171.83 | 2022 | |
| Novo Nordisk INC | $148.84 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.01 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.79 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.74 | 2021-2022 | |
| Lilly USA, LLC | $45.84 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $45.33 | 2023-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $43.66 | 2023-2024 | Watchman Flx, Superion Indirect Decompression System |
| Nevro Corp. | $34.43 | 2022 | |
| Amgen INC. | $32.45 | 2022-2023 | Prolia, Evenity |
| Teleflex LLC | $27.57 | 2022 | |
| Medtronic, INC. | $23.09 | 2023 | Intellis Adaptivestim |
| Ultragenyx Pharmaceutical INC. | $20.86 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.01 | 2022 | |
| Lucid Diagnostics INC. | $16.41 | 2022 | |
| Pfizer INC. | $16.13 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.49 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.38 | 2022 | |
| Axonics, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cresap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.